Publishing their work in Nature, UNC School of Medicine researchers with the UNC McAllister Heart Institute show how their new research platform helped them discover new cell subpopulations and crucial cellular players in the process of turning damaged heart tissue back into healthy heart muscle. The research platform could be used to study other biological processes and create tailored therapies.

Brian Jensen, MD, associate professor of medicine and pharmacology, and colleagues identified for the first-time mechanisms underlying the cardiotoxicity of kinase inhibitors used to treat cancer.

Calculating the risk of heart failure, cardiogenic shock, and death at the time of an angioplasty procedure can be critically important because early initiation of blood pressure support can improve survival.

In May, a faulty heart valve nearly put an end to Jim Weber. But after receiving a transcatheter aortic valve replacement at UNC Medical Center, Weber says he feels like he’s been gifted with years he didn’t have before. A lifelong Notre Dame fan, Weber joined Matt Cavender, the doctor who performed the valve replacement, as the Fighting Irish faced the Tar Heels at Kenan Stadium.

Myron Cohen, MD, from the division of infectious diseases has co-authored a perspective about broadly neutralizing antibodies.

Dr. Saira Sheikh, Dr. Carlton Moore and Dr. Richard Wardrop have been selected to participate in the UNC School of Medicine’s Academic Career Leadership Academy in Medicine (ACCLAIM).

A reception to honor the life of renowned researcher and beloved faculty member Harold Roberts, MD, will be held Saturday, November 11 from 5 – 7 p.m. at the Carolina Club.

Atrial fibrillation hospitalizations reduced by 30 percentage points in first year of program.

Patients come because they know UNC cares. The division of hospital medicine responds with care plans that better serve them, and this contributes to physician wellbeing.

Dr. Sean Gaffney wins the department of medicine’s first “discharge competition.”

Nigel Mackman, PhD, John Parker Distinguished Professor of Medicine in the Division of Hematology/Oncology, has been selected by the American Heart Association and the Council on Arteriosclerosis, Thrombosis and Vascular Biology (ATVB) to receive the 2017 ATVB Distinguished Achievement Award.

William A. Fischer II, M.D., an assistant professor in the division of pulmonary and critical care medicine and David A. Wohl, M.D., in the division of infectious diseases discuss how the Ebola virus RNA can persist in the semen of survivors more than two years after the onset of infection.